NCT00134628

Brief Summary

The principle objective of this research is to more precisely determine the degree of benefit that hyperbaric oxygen therapy affords in the treatment of late radiation tissue injury. The study has eight\* components. Seven involve the evaluation of established radionecrosis at varying anatomic sites (mandible, larynx, skin, bladder, rectum, colon, and gyn). The eighth will investigate the potential of hyperbaric oxygen (HBO) therapy to prophylax against late radiation tissue injury. \*(One of the arms, HORTIS IV - Proctitis has been closed to further patient recruitment. This decision was based on an interim statistical analysis which generated sufficient evidence to support closing down this arm of HORTIS.)

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
248

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Jan 2001

Longer than P75 for phase_3

Geographic Reach
5 countries

7 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2001

Completed
4.6 years until next milestone

First Submitted

Initial submission to the registry

August 23, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 25, 2005

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2011

Completed
4.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

January 12, 2016

Status Verified

February 1, 2012

Enrollment Period

10.6 years

First QC Date

August 23, 2005

Last Update Submit

January 11, 2016

Conditions

Keywords

Hyperbaric OxygenationRadiation injuriesProphylaxisProctitisCystitisEnteritisOsteoradionecrosis

Outcome Measures

Primary Outcomes (1)

  • SOMA (Subjective, Objective, Management, Analytic) scale used to determine late effects to normal tissue (LENT) score

    pre-treatment, post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years

Secondary Outcomes (6)

  • Clinical assessment using one of the following criteria:

    post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years

  • Healed

    post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years

  • Modestly improved (< 50% lesion resolution)

    post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years

  • Not improved

    post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years

  • Other (e.g. lesion recurrence, lesion size progression)

    post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years

  • +1 more secondary outcomes

Study Arms (2)

A

ACTIVE COMPARATOR

Hyperbaric Oxygen Therapy

Procedure: Hyperbaric Oxygen Therapy

B

SHAM COMPARATOR

Normal Air

Procedure: Sham treatment

Interventions

HBO at 2.0 ATA

A

Normal air under pressure (1.1 ATA)

B

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Endarteritis
  • Hypovascularity
  • Diarrhea
  • Cramping
  • Obstruction
  • Stricture
  • Pain
  • Hemorrhage
  • Wall Changes
  • Ulceration
  • Hypocellularity
  • Mucosal thickening
  • Vomiting
  • Tenesmus
  • Constipation
  • +4 more criteria

You may not qualify if:

  • Pregnancy
  • Reactive airway disease
  • Radiographic evidence of pulmonary blebs or bullae
  • Untreated pneumothorax
  • Previously documented ejection fraction less than 35%
  • History of seizures except childhood febrile seizures
  • Cardiovascular instability
  • Mechanical ventilator support with the exception of those patients who are immediately (1-5 days) post-operative
  • Unable to follow simple commands
  • Not orientated to person, place, time
  • Participating as a subject in any other medical or biomedical research project; if previously involved as a subject, sufficient time must have elapsed to permit "wash out" of any investigational agent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Palmetto Health Richland

Columbia, South Carolina, 29203, United States

Location

Wesley Medical Center

Brisbane, Queensland, 4064, Australia

Location

Royal Hobart Hospital

Hobart, Tasmania, 7001, Australia

Location

Instituto Nacional de Cancerologica

Mexico City, 14080, Mexico

Location

University of Stellenbosch

Cape Town, South Africa

Location

University of Pretoria Medical Center

Pretoria, 0001, South Africa

Location

Istanbul University Medical Center

Istanbul, 34390, Turkey (Türkiye)

Location

Related Publications (10)

  • Curi MM, Dib LL. Osteoradionecrosis of the jaws: a retrospective study of the background factors and treatment in 104 cases. J Oral Maxillofac Surg. 1997 Jun;55(6):540-4; discussion 545-6. doi: 10.1016/s0278-2391(97)90478-x.

    PMID: 9191633BACKGROUND
  • Joseph DL, Shumrick DL. Risks of head and neck surgery in previously irradiated patients. Arch Otolaryngol. 1973 May;97(5):381-4. doi: 10.1001/archotol.1973.00780010393005. No abstract available.

    PMID: 4703530BACKGROUND
  • Samuels L, Granick MS, Ramasastry S, Solomon MP, Hurwitz D. Reconstruction of radiation-induced chest wall lesions. Ann Plast Surg. 1993 Nov;31(5):399-405. doi: 10.1097/00000637-199311000-00003.

    PMID: 8285524BACKGROUND
  • Hart GB, Mainous EG. The treatment of radiation necrosis with hyperbaric oxygen (OHP). Cancer. 1976 Jun;37(6):2580-5. doi: 10.1002/1097-0142(197606)37:63.0.co;2-h.

    PMID: 949677BACKGROUND
  • Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983 May;41(5):283-8. doi: 10.1016/0278-2391(83)90294-x.

    PMID: 6572704BACKGROUND
  • Marx RE. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg. 1983 Jun;41(6):351-7. doi: 10.1016/s0278-2391(83)80005-6. No abstract available.

    PMID: 6574217BACKGROUND
  • Bevers RF, Bakker DJ, Kurth KH. Hyperbaric oxygen treatment for haemorrhagic radiation cystitis. Lancet. 1995 Sep 23;346(8978):803-5. doi: 10.1016/s0140-6736(95)91620-2.

    PMID: 7674746BACKGROUND
  • Woo TC, Joseph D, Oxer H. Hyperbaric oxygen treatment for radiation proctitis. Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):619-22. doi: 10.1016/s0360-3016(97)00017-5.

    PMID: 9231688BACKGROUND
  • Williams JA Jr, Clarke D, Dennis WA, Dennis EJ 3rd, Smith ST. The treatment of pelvic soft tissue radiation necrosis with hyperbaric oxygen. Am J Obstet Gynecol. 1992 Aug;167(2):412-5; discussion 415-6. doi: 10.1016/s0002-9378(11)91421-5.

    PMID: 1497044BACKGROUND
  • Feldmeier JJ, Heimbach RD, Davolt DA, Brakora MJ. Hyperbaric oxygen as an adjunctive treatment for severe laryngeal necrosis: a report of nine consecutive cases. Undersea Hyperb Med. 1993 Dec;20(4):329-35.

    PMID: 8286987BACKGROUND

MeSH Terms

Conditions

Radiation InjuriesProctitisCystitisEnteritisOsteoradionecrosis

Interventions

Hyperbaric Oxygenation

Condition Hierarchy (Ancestors)

Wounds and InjuriesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesRectal DiseasesIntestinal DiseasesUrinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Oxygen Inhalation TherapyRespiratory TherapyTherapeutics

Study Officials

  • Dick Clarke, CHT

    National Baromedical Services

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
President, National Baromedical Research Foundation

Study Record Dates

First Submitted

August 23, 2005

First Posted

August 25, 2005

Study Start

January 1, 2001

Primary Completion

August 1, 2011

Study Completion

December 1, 2015

Last Updated

January 12, 2016

Record last verified: 2012-02

Locations